Time Sink

#242: Depends on How Many Eyes You Rip Out


Listen Later

Ozempic holding an economy hostage, Denmark potentially following in Finland’s footsteps, and Hamza’s “Sus” topic, all this and more on this week’s visit to the Time Sink!


Show Notes:

Ozempic

Wegovy

Novo Nordisk

FDA Approval

Market Share

Novo Nordisk 2024 Annual Report

NPR Article

Largest European Companies (by revenue)

Semaglutide

Eyestalk Ablation

Horseshoe Crab Use in Medicine

...more
View all episodesView all episodes
Download on the App Store

Time SinkBy TimeSink

  • 4.2
  • 4.2
  • 4.2
  • 4.2
  • 4.2

4.2

9 ratings